CM Life Sciences III Inc. (CMLT) Comparison with companies in other sectors?

CM Life Sciences III Inc. has a share price of 488.60M. You can analyze CM Life Sciences III Inc. (CMLT) competitors across different market sectors through stock heatmaps.

What are CMLT's NET and operating margins?

CM Life Sciences III Inc. (CMLT) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does CMLT's earnings per share (EPS) trend reflect its financial momentum?

CM Life Sciences III Inc. (CMLT) EPS is N/A (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for CM Life Sciences III Inc. is N/A, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for CM Life Sciences III Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for CM Life Sciences III Inc. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

CM Life Sciences III Inc.

CMLT•NASDAQ

Financial Services

Shell Companies

$8.69

$-0.52(-5.65%)

U.S. Market opens in 6h 28m

CM Life Sciences III Inc. Fundamental Analysis

CM Life Sciences III Inc. (CMLT) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze CMLT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze CMLT's fundamental strength across five key dimensions:

Efficiency Score

Weak

CMLT struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

CMLT trades at a premium to fair value.

PE < 25

N/A

PEG Ratio < 2

N/A

Growth Score

Weak

CMLT faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

CMLT carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

CMLT struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is CMLT Expensive or Cheap?

No data available.

How Well Does CMLT Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How CMLT Stacks Against Its Sector Peers

Metric	CMLT Value	Sector Average	Performance
P/E Ratio	N/A	19.09	N/A
ROE	N/A	843.00%	N/A
Net Margin	N/A	3730.00%	N/A
Debt/Equity	N/A	0.90	N/A
Current Ratio	N/A	661.68	N/A
ROA	N/A	-21651.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CM Life Sciences III Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

CM Life Sciences III Inc. Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is CMLT Expensive or Cheap?

How Well Does CMLT Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How CMLT Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

CM Life Sciences III Inc. (CMLT) Comparison with companies in other sectors?

What are CMLT's NET and operating margins?

In what way does CMLT's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for CM Life Sciences III Inc.?

How do I know if AAPL is overvalued or undervalued?